65,437 trials
Care, Postoperative · Pain, Postoperative · Surgical Procedures, Operative
Primary: Modified Yale Preoperative Anxiety Scale — 41.59; 37.44; 46.17; 33.65 Score on mYPAS scale — p=.02
Stroke, Ischemic
Primary: Successful Revascularization Rate — 42 Participants
Covid19
Primary: Sensitivity of Detecting SARS-CoV-2 RNA — 31; 0 Participants
Head and Neck Cancer · Radiation Dermatitis
Primary: Completion Rate of Use of KeraStat Cream — 10; 7 Participants
Primary Axillary Hyperhidrosis
Primary: Safety of the N-SWEAT Patch — 14; 4 Participants
Ulcerative Colitis
Primary: Percentage of Participants Who Achieved a Clinical Response by Total Mayo Score at Day 57 — 63.6; 54.5; 54.5 Percentage of participants — p=1.0000
Depression · Osteoarthritis
Primary: Attendance of the Fit & Strong! Intervention Classes — 10 Classes attended
Respiratory Syncytial Virus Prevention
Primary: Geometric Mean Titers (GMTs) of Prefusion F-protein (preF) Antibodies as Assessed by Enzyme-linked Immunosorbent Assay (ELISA) 14 Days Post Vaccination — 4277; 4121…
Vaccines, Combined · Hexavalent Vaccine
Primary: Percentage of Participants With a Solicited Injection-site Adverse Event (AE) — 52.9; 50.0; 74.1; 56.1 Percentage of participants
Heart Disease · Myocardial Infarction · Acute Myocardial Infarction
Primary: Mortality at 30 Days — 1; 7; 3; 2 participants
Osteoarthritis · Osteo Arthritis Knee
Primary: Change From Baseline in Average Pain Intensity as Measured by the Numeric Rating Scale (NRS) — -0.95; -1.18 score on a scale
Rheumatoid Arthritis
Primary: Changes in Clinical Disease Activity Index (CDAI) Between Week 0 and Week 12 — 8 Participants
Skin Pigment · Photoaging
Primary: Degree of Improvement Rating at 12 Weeks Post-final Treatment — 1.4 score on a scale
Bariatric Surgery
Primary: Number of Intervention Sessions Completed — 8.5 sessions
Recurrent Multiple Myeloma · Refractory Multiple Myeloma
Primary: Number of Participants Experiencing a Dose Limiting Toxicity (Dose Escalation) — 0; 0; 0; 3 Participants